We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a quasi-experimental study to evaluate your digital health product.
Nearly 20 million doses of potentially dangerous medicines prevented from reaching the public
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Guidance for clinical trials that use Decentralised Manufactured Investigational Medicinal Products (IMPs).
How to use a micro-randomised trial to evaluate your digital health product.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
The Intellectual Property Office offers different methods of accelerating the processing of your patent application.
AI Exemplars are transforming public services – improving healthcare, education, planning and justice with practical and innovative AI solutions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).